The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Karen Knudsen, PhD, has been appointed CEO of San Francisco-based Parker Institute for Cancer Immunotherapy. Dr. Knudsen previously served as CEO for both the American Cancer Society and ACS Cancer ...